582 related articles for article (PubMed ID: 21826714)
1. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
[TBL] [Abstract][Full Text] [Related]
2. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women.
Zhang W; Song Y; He X; Huang H; Xu B; Song J
Neurourol Urodyn; 2006; 25(7):717-21. PubMed ID: 16944449
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
5. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
[TBL] [Abstract][Full Text] [Related]
7. National community prevalence of overactive bladder in the United States stratified by sex and age.
Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
[TBL] [Abstract][Full Text] [Related]
8. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
[TBL] [Abstract][Full Text] [Related]
10. Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007.
Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
BJU Int; 2009 Oct; 104(7):954-9. PubMed ID: 19388983
[TBL] [Abstract][Full Text] [Related]
11. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
[TBL] [Abstract][Full Text] [Related]
13. An epidemiological survey of overactive bladder symptoms in Japan.
Homma Y; Yamaguchi O; Hayashi K;
BJU Int; 2005 Dec; 96(9):1314-8. PubMed ID: 16287452
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and burden of overactive bladder in the United States.
Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ
World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491
[TBL] [Abstract][Full Text] [Related]
15. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women.
Teleman PM; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A;
BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789
[TBL] [Abstract][Full Text] [Related]
16. Impact of overactive bladder symptoms on sexuality in both sexes.
Heidler S; Mert C; Wehrberger C; Temml C; Ponholzer A; Rauchenwald M; Madersbacher S
Urol Int; 2010; 85(4):443-6. PubMed ID: 20962511
[TBL] [Abstract][Full Text] [Related]
17. Burden of overactive bladder symptom on quality of life in stroke patients.
Itoh Y; Yamada S; Konoeda F; Koizumi K; Nagata H; Oya M; Suzuki N
Neurourol Urodyn; 2013 Jun; 32(5):428-34. PubMed ID: 23129306
[TBL] [Abstract][Full Text] [Related]
18. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
19. Redefining response in overactive bladder syndrome.
Payne CK; Kelleher C
BJU Int; 2007 Jan; 99(1):101-6. PubMed ID: 17227496
[TBL] [Abstract][Full Text] [Related]
20. [Impact of urinary incontinence and overactive bladder syndrome on health-related quality of life of working middle-aged patients and institutionalized elderly patients].
Martínez Agulló E; Ruíz Cerdá JL; Gómez Pérez L; Rebollo P; Pérez M; Chaves J
Actas Urol Esp; 2010 Mar; 34(3):242-50. PubMed ID: 20416241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
